Nuclear factor-kappa B and interleukin-6 related docetaxel resistance in castration-resistant prostate cancer
Author:
Publisher
Wiley
Subject
Urology,Oncology
Reference37 articles.
1. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer;Petrylak;N Engl J Med,2004
2. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004
3. Phase II trial of short-term neoadjuvant docetaxel and complete androgen blockade in high-risk prostate cancer;Mellado;Br J Cancer,2009
4. Serum HER2 extracellular domain predicts an aggressive clinical outcome and biological PSA response in hormone-independent prostate cancer patients treated with docetaxel;Domingo-Domenech;Ann Oncol,2008
5. Interleukin 6, a nuclear factor-kappaB target, predicts resistance to docetaxel in hormone-independent prostate cancer and nuclear factor-kappaB inhibition by PS-1145 enhances docetaxel antitumor activity;Domingo-Domenech;Clin Cancer Res,2006
Cited by 51 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Role of Ciminalum-4-thiazolidinone Hybrids in Molecular NF-κB Dependent Pathways;International Journal of Molecular Sciences;2024-07-03
2. Treatment strategies and drug resistance mechanisms in adenocarcinoma of different organs;Drug Resistance Updates;2023-11
3. Inhibition of Ribonucleotide Reductase Induces Endoplasmic Reticulum Stress and Apoptosis, Leading to the Death of Docetaxel-resistant Prostate Cancer Cells;Anti-Cancer Agents in Medicinal Chemistry;2023-10
4. STAT signaling as a target for intervention: from cancer inflammation and angiogenesis to non-coding RNAs modulation;Molecular Biology Reports;2022-04-26
5. Inflammatory molecules facilitate the development of docetaxel‐resistant prostate cancer cells in vitro and in vivo;Fundamental & Clinical Pharmacology;2022-03-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3